Reyataz label Evotaz label
Interaction Color Code
Clinical Bottom Line
Do not coadminister: Potential for increased levels of ranolazine
Drug 1
Drug 2
Clinical Effects
Potential increase in ranolazine adverse effects (e.g. prolonged QT, cardiac arrythmias).
Management
Contraindicated. Use alternative agents.
Import ID
829
